Empowering Cisgender Women: Inclusion and Awareness of PrEP

Shobha Swaminathan, MD, FIDSA
Professor and Director of HIV Services, Division of Infectious Diseases
Department of Medicine, Rutgers, The State University of New Jersey
Newark, NJ

CME VIDEOTop of page

How to Obtain CME Credit:Top of page

Click here to take the CME Evaluation and Post-Meeting Survey

About the Presenter:Top of page

Dr. Shobha Swaminathan is Professor of Medicine and Director of HIV Programs at Rutgers New Jersey Medical School. She is also the clinical research site leader At Research With a Heart, the NIH-funded clinical trials unit at New Jersey Medical School. Dr. Swaminathan is the principal investigator of many clinical grants to provide HIV testing, care and treatment. Her research interests include clinical trials for HIV treatment and Prevention, and she is the site PI for multiple HIV testing grants. She also leads a very active community engagement team dedicated to increasing awareness about HIV and the importance of clinical research in helping to address the HIV epidemic.

Learning Objectives: Top of page

At the completion of this educational activity learners will:
1. Understand PrEP eligibility and benefits in cisgender women.
2. Be able to navigate the PrEP prescription process.
3. Know how to monitor adherence strategies.
4. Be aware of the pipeline for new PrEP options.

CME Information:Top of page

This CME activity has approved for AMA PRA Category 1 Credit™ for November 8, 2023, as a live activity. This activity will also be available as an enduring activity from November 15, 2023, through November 7, 2026.

The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length.

Accreditation Statement:Top of page

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement:Top of page

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure Statement:Top of page

Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices, or services may be discussed in the content of a CME activity.
- Dr. James F. Braun (Course Director/Planner) has no relevant financial relationships to disclose.
- Dr. Kristen Marks (Moderator) has no relevant financial relationships to disclose.
- Dr. Shobha Swaminathan (Presenter) has had the following relevant financial relationships in the past 24 months with manufacturers of the products or services that may be presented in this CME activity: Advisory Board to ViiV. Dr. Swaminathan submitted her slides in advance for adequate peer review and supported her presentation and clinical recommendations with the best available evidence from the medical literature. All relevant financial relationships were mitigated.

Financial Support:Top of page

This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare

You must be logged in to post a comment. Login | Register